122 related articles for article (PubMed ID: 37263260)
1. Alterations of UHRF Family Expression and UHRF1/ICBP90 Inhibits Phosphatase and Tensin Homolog Expression in Endometrial Cancer.
Yoshimoto M; Tokuda A; Eguchi A; Nozawa Y; Mori T; Yaginuma Y
Oncology; 2023; 101(7):457-468. PubMed ID: 37263260
[TBL] [Abstract][Full Text] [Related]
2. Alterations of UHRF family Expression and was regulated by High Risk Type HPV16 in Uterine Cervical Cancer.
Yoshimoto M; Tokuda A; Eguchi A; Nozawa Y; Mori T; Yaginuma Y
Exp Cell Res; 2024 Apr; 437(2):114018. PubMed ID: 38556072
[TBL] [Abstract][Full Text] [Related]
3. A concern regarding the current confusion with the human homolog of mouse Np95, ICBP90/UHRF1.
Unoki M; Bronner C; Mousli M
Radiat Res; 2008 Feb; 169(2):240-4. PubMed ID: 18220474
[TBL] [Abstract][Full Text] [Related]
4. ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells.
Mousli M; Hopfner R; Abbady AQ; Monté D; Jeanblanc M; Oudet P; Louis B; Bronner C
Br J Cancer; 2003 Jul; 89(1):120-7. PubMed ID: 12838312
[TBL] [Abstract][Full Text] [Related]
5. The UHRF protein family in epigenetics, development, and carcinogenesis.
Unoki M; Sasaki H
Proc Jpn Acad Ser B Phys Biol Sci; 2022; 98(8):401-415. PubMed ID: 36216533
[TBL] [Abstract][Full Text] [Related]
6. Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma.
Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
J Med Assoc Thai; 2008 Aug; 91(8):1161-5. PubMed ID: 18788685
[TBL] [Abstract][Full Text] [Related]
7. Correlation between NDRG1 and PTEN expression in endometrial carcinoma.
Chen J; Li S; Yang Z; Lu G; Hu H
Cancer Sci; 2008 Apr; 99(4):706-10. PubMed ID: 18377423
[TBL] [Abstract][Full Text] [Related]
8. lncRNA LA16c‑313D11.11 modulates the development of endometrial cancer by binding to and inhibiting microRNA‑205‑5p function and indirectly increasing PTEN activity.
Xin W; Zhao S; Han X; Zhao P; Yu H; Gao X; Li P; Wu Q; Ding J; Hua K
Int J Oncol; 2020 Jul; 57(1):355-363. PubMed ID: 32319598
[TBL] [Abstract][Full Text] [Related]
9. Expression of PTTG1 and PTEN in endometrial carcinoma: correlation with tumorigenesis and progression.
Feng ZZ; Chen JW; Yang ZR; Lu GZ; Cai ZG
Med Oncol; 2012 Mar; 29(1):304-10. PubMed ID: 21181309
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.
Alhosin M; Sharif T; Mousli M; Etienne-Selloum N; Fuhrmann G; Schini-Kerth VB; Bronner C
J Exp Clin Cancer Res; 2011 Apr; 30(1):41. PubMed ID: 21496237
[TBL] [Abstract][Full Text] [Related]
11. The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?
Bronner C; Achour M; Arima Y; Chataigneau T; Saya H; Schini-Kerth VB
Pharmacol Ther; 2007 Sep; 115(3):419-34. PubMed ID: 17658611
[TBL] [Abstract][Full Text] [Related]
12. Immunoexpression of Cyclin D1 and PTEN in Various Endometrial Pathologies.
Shawana S; Kehar SI; Masood S; Aamir I
J Coll Physicians Surg Pak; 2016 Apr; 26(4):277-82. PubMed ID: 27097697
[TBL] [Abstract][Full Text] [Related]
13. MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer Ishikawa cells.
Zhang G; Hou X; Li Y; Zhao M
BMC Cancer; 2014 Jun; 14():440. PubMed ID: 24929707
[TBL] [Abstract][Full Text] [Related]
14. PTEN mutations as predictive marker for the high-grade endometrial cancer development in slovak women.
Gbelcová H; Gergely L; Šišovský V; Straka Ľ; Böhmer D; Pastoráková A; Sušienková K; Repiská V; Korbeľ M; Danihel Ľ; Priščáková P
Physiol Res; 2022 Dec; 71(Suppl 1):S125-S135. PubMed ID: 36592448
[TBL] [Abstract][Full Text] [Related]
15. Expression Profiles of the Phosphatase and Tensin Homolog (PTEN), CDH1, and CDH2 Genes, and the Cell Membrane Protein, CD133, in the Ishikawa Human Endometrial Adenocarcinoma Cell Line.
Lee P; Li X
Med Sci Monit; 2019 Dec; 25():9829-9835. PubMed ID: 31864232
[TBL] [Abstract][Full Text] [Related]
16. Endometrial tumorigenesis in Pten(+/-) mice is independent of coexistence of estrogen and estrogen receptor α.
Joshi A; Wang H; Jiang G; Douglas W; Chan JS; Korach KS; Ellenson LH
Am J Pathol; 2012 Jun; 180(6):2536-47. PubMed ID: 22503752
[TBL] [Abstract][Full Text] [Related]
17. Molecular investigation of the tandem Tudor domain and plant homeodomain histone binding domains of the epigenetic regulator UHRF2.
Ginnard SM; Winkler AE; Mellado Fritz C; Bluhm T; Kemmer R; Gilliam M; Butkevich N; Abdrabbo S; Bricker K; Feiler J; Miller I; Zoerman J; El-Mohri Z; Khuansanguan P; Basch M; Petzold T; Kostoff M; Konopka S; Kociba B; Gillis T; Heyl DL; Trievel RC; Albaugh BN
Proteins; 2022 Mar; 90(3):835-847. PubMed ID: 34766381
[TBL] [Abstract][Full Text] [Related]
18. Identification of UHRF1/2 as new N-methylpurine DNA glycosylase-interacting proteins.
Liang C; Zhang X; Song S; Tian C; Yin Y; Xing G; He F; Zhang L
Biochem Biophys Res Commun; 2013 Apr; 433(4):415-9. PubMed ID: 23537643
[TBL] [Abstract][Full Text] [Related]
19. ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation.
Karagianni P; Amazit L; Qin J; Wong J
Mol Cell Biol; 2008 Jan; 28(2):705-17. PubMed ID: 17967883
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of ICBP90 by protein kinase A enhances topoisomerase IIalpha expression.
Trotzier MA; Bronner C; Bathami K; Mathieu E; Abbady AQ; Jeanblanc M; Muller CD; Rochette-Egly C; Mousli M
Biochem Biophys Res Commun; 2004 Jun; 319(2):590-5. PubMed ID: 15178447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
